Simplex Trading’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-693
| Closed | -$9.5K | – | 9219 |
|
|
2026
Q1 | $8.61K | Buy |
+693
| New | +$9.3K | ﹤0.01% | 7480 |
|
|
2025
Q3 | – | Sell |
-70,527
| Closed | -$633K | – | 8975 |
|
|
2025
Q2 | $570K | Buy |
70,527
+1,978
| +3% | +$14.9K | ﹤0.01% | 3363 |
|
|
2025
Q1 | $574K | Buy |
68,549
+68,278
| +25,195% | +$570K | ﹤0.01% | 3249 |
|
|
2024
Q4 | $2K | Sell |
271
-3,891
| -93% | -$32.6K | ﹤0.01% | 7962 |
|
|
2024
Q3 | $34K | Buy |
4,162
+2,059
| +98% | +$16.1K | ﹤0.01% | 6225 |
|
|
2024
Q2 | $13K | Buy |
+2,103
| New | +$13.4K | ﹤0.01% | 7223 |
|
|
2023
Q3 | – | Sell |
-430
| Closed | -$1.6K | – | 8568 |
|
|
2023
Q2 | $1K | Sell |
430
-55
| -11% | -$117 | ﹤0.01% | 8561 |
|
|
2023
Q1 | $0 | Buy |
+485
| New | +$966 | ﹤0.01% | 8924 |
|
|
2022
Q4 | – | Sell |
-3,281
| Closed | -$7.36K | – | 9117 |
|
|
2022
Q3 | $6K | Sell |
3,281
-3,230
| -50% | -$9.05K | ﹤0.01% | 8610 |
|
|
2022
Q2 | $20K | Sell |
6,511
-137,220
| -95% | -$497K | ﹤0.01% | 7591 |
|
|
2022
Q1 | $599K | Buy |
143,731
+46,733
| +48% | +$207K | ﹤0.01% | 3597 |
|
|
2021
Q4 | $464K | Buy |
+96,998
| New | +$484K | ﹤0.01% | 3915 |
|
|
2021
Q2 | – | Sell |
-1,213
| Closed | -$6.89K | – | 9961 |
|
|
2021
Q1 | $8K | Sell |
1,213
-17,692
| -94% | -$98.1K | ﹤0.01% | 7999 |
|
|
2020
Q4 | $86K | Buy |
18,905
+6,875
| +57% | +$30.5K | ﹤0.01% | 5590 |
|
|
2020
Q3 | $46K | Buy |
12,030
+9,603
| +396% | +$41.1K | ﹤0.01% | 5666 |
|
|
2020
Q2 | $11K | Sell |
2,427
-3,034
| -56% | -$12.5K | ﹤0.01% | 6582 |
|
|
2020
Q1 | $19K | Sell |
5,461
-3,014
| -36% | -$12.8K | ﹤0.01% | 5985 |
|
|
2019
Q4 | $40K | Buy |
8,475
+4,973
| +142% | +$17.3K | ﹤0.01% | 5395 |
|
|
2019
Q3 | $10K | Sell |
3,502
-1,048
| -23% | -$3.66K | ﹤0.01% | 6232 |
|
|
2019
Q2 | $32K | Sell |
4,550
-1,319
| -22% | -$13.5K | ﹤0.01% | 5215 |
|
|
2019
Q1 | $83K | Buy |
5,869
+949
| +19% | +$12.5K | ﹤0.01% | 4540 |
|
|
2018
Q4 | $66K | Sell |
4,920
-22,485
| -82% | -$405K | ﹤0.01% | 4256 |
|
|
2018
Q3 | $608K | Buy |
27,405
+297
| +1% | +$6.25K | ﹤0.01% | 2418 |
|
|
2018
Q2 | $444K | Buy |
+27,108
| New | +$476K | ﹤0.01% | 2581 |
|
Other funds holding AMRX
TGA
RCMNY
Simplex Trading's AMRX Position: Q2 2026 in Review
Simplex Trading sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 693 shares — an estimated $9.5K sold.
Simplex Trading first reported a position in AMRX in Q2 2018 and held it in 24 quarters. The position peaked at $608K in Q3 2018. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Simplex Trading reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 693 Amneal Pharmaceuticals shares in Q2 2026, an estimated $9.5K.
- Simplex Trading first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 24 quarters.
- Simplex Trading's Amneal Pharmaceuticals position peaked at $608K in Q3 2018.
- 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.